These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24401872)

  • 1. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients.
    Alvarado AS; Malvar A; Lococo B; Alberton V; Toniolo F; Nagaraja HN; Rovin BH
    Lupus; 2014 Jul; 23(8):840-7. PubMed ID: 24401872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy.
    De Rosa M; Azzato F; Toblli JE; De Rosa G; Fuentes F; Nagaraja HN; Nash R; Rovin BH
    Kidney Int; 2018 Oct; 94(4):788-794. PubMed ID: 30045812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis.
    Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau FA; Tamirou F
    Rheumatology (Oxford); 2020 Nov; 59(11):3424-3434. PubMed ID: 32353879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive risk factors for failure to induction therapy of lupus nephritis in a cohort of Colombian patients.
    Pinto Peñaranda LF; Castro Mercado IL; Duque Caballero V; Márquez Hernández JD; Velásquez Franco CJ
    Reumatol Clin; 2014; 10(3):147-51. PubMed ID: 24269070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
    Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH
    J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
    Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
    Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis.
    Capuano A; Costanzi S; Peluso G; Zannoni G; Vellone VG; Gremese E; Zoli A; Scott C; Beltrami CA; Romano G; Ferraccioli G
    Arthritis Rheum; 2006 Nov; 54(11):3633-9. PubMed ID: 17075808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
    Das U; Patel R; Guditi S; Taduri G
    Lupus; 2021 May; 30(6):876-883. PubMed ID: 33611965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of repeat renal biopsies in the management of lupus nephritis: a South African experience.
    Tannor EK; Bates WD; Moosa MR
    Lupus; 2018 Apr; 27(4):525-535. PubMed ID: 28820361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new morphologic index for the evaluation of renal biopsies in lupus nephritis.
    Hill GS; Delahousse M; Nochy D; Tomkiewicz E; Rémy P; Mignon F; Méry JP
    Kidney Int; 2000 Sep; 58(3):1160-73. PubMed ID: 10972679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.
    Malvar A; Alberton V; Lococo B; Ferrari M; Delgado P; Nagaraja HN; Rovin BH
    Kidney Int; 2020 Jan; 97(1):156-162. PubMed ID: 31685314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
    Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis.
    Wang GB; Xu ZJ; Liu HF; Zhou QG; Zhou ZM; Jia N
    Chin Med J (Engl); 2012 Aug; 125(16):2890-4. PubMed ID: 22932086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.